Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
18.50
+0.71 (3.99%)
At close: Jan 16, 2026, 4:00 PM EST
18.33
-0.17 (-0.92%)
After-hours: Jan 16, 2026, 7:45 PM EST
Beta Bionics Market Cap
Beta Bionics has a market cap or net worth of $814.46 million as of January 16, 2026.
Market Cap
814.46M
Enterprise Value
593.46M
1-Year Change
n/a
Ranking
Category
Stock Price
$18.50
Market Cap Chart
Since the IPO on January 30, 2025, Beta Bionics's market cap has increased from $695.12M to $814.46M, an increase of 17.17%. That is a compound annual growth rate of 17.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 814.46M | -39.28% |
| Dec 31, 2025 | 1.34B | 92.98% |
| Jan 30, 2025 | 695.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |